These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Immune reconstitution and outcome after unrelated cord blood transplantation: a single paediatric institution experience. Giraud P; Thuret I; Reviron D; Chambost H; Brunet C; Novakovitch G; Farnarier C; Michel G Bone Marrow Transplant; 2000 Jan; 25(1):53-7. PubMed ID: 10654015 [TBL] [Abstract][Full Text] [Related]
13. Quantitative and qualitative CD4 T cell immune responses related to adenovirus DNAemia in hematopoietic stem cell transplantation. Guérin-El Khourouj V; Dalle JH; Pédron B; Yakouben K; Bensoussan D; Cordeiro DJ; Peltier L; Ouachée-Chardin M; Baruchel A; Sterkers G Biol Blood Marrow Transplant; 2011 Apr; 17(4):476-85. PubMed ID: 20869455 [TBL] [Abstract][Full Text] [Related]
14. Immunological reconstitution and correlation of circulating serum inflammatory mediators/cytokines with the incidence of acute graft-versus-host disease during the first 100 days following unrelated umbilical cord blood transplantation. Abu-Ghosh A; Goldman S; Slone V; van de Ven C; Suen Y; Murphy L; Sender L; Cairo M Bone Marrow Transplant; 1999 Sep; 24(5):535-44. PubMed ID: 10482939 [TBL] [Abstract][Full Text] [Related]
15. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications. Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930 [TBL] [Abstract][Full Text] [Related]
16. Clinical grade expansion of CD45RA, CD45RO, and CD62L-positive T-cell lines from HLA-compatible donors: high cytotoxic potential against AML and ALL cells. Barbui AM; Borleri G; Conti E; Ciocca A; Salvi A; Micò C; Introna M; Rambaldi A Exp Hematol; 2006 Apr; 34(4):475-85. PubMed ID: 16569594 [TBL] [Abstract][Full Text] [Related]
17. Immune reconstitution following myeloablative allogeneic hematopoietic stem cell transplantation: the impact of expanding CD28negative CD8+ T cells on relapse. Yakoub-Agha I; Saule P; Magro L; Cracco P; Duhamel A; Coiteux V; Bruno B; Dufossé F; Jouet JP; Dessaint JP; Labalette M Biol Blood Marrow Transplant; 2009 Apr; 15(4):496-504. PubMed ID: 19285638 [TBL] [Abstract][Full Text] [Related]
18. Rapid helper T-cell recovery above 200 x 10 6/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation. Kim DH; Sohn SK; Won DI; Lee NY; Suh JS; Lee KB Bone Marrow Transplant; 2006 Jun; 37(12):1119-28. PubMed ID: 16699530 [TBL] [Abstract][Full Text] [Related]
19. Early recovery of immunity after cord-blood transplantation in children: qualitative features and impact of cytomegalovirus infection. Farnault L; Chambost H; Zandotti C; Mallet F; Barlogis V; Galambrun C; Michel G; Olive D Acta Haematol; 2012; 128(1):7-16. PubMed ID: 22555589 [TBL] [Abstract][Full Text] [Related]